Catheter Precision reports H1 2023 revenue $181k, cash $7.4M; VIVO registry fully enrolled

Catheter Precision, Inc.

Total revenue for six months ended June 30, 2023 was $181,000.
Cash and cash equivalents $7.4 million; total assets $35.5 million at June 30, 2023.
Completed enrollment of 125-patient VIVO registry; follow-up data expected June 2024.
Initiated first LockeT study (100 patients) to demonstrate time to hemostasis and ambulation.
Merger accounting between Ra Medical and Catheter Precision completed.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.75

Catheter Precision, Inc. reported financial results for the three and six months ended June 30, 2023.

Period: the three and six months ended June 30, 2023
Result: reported results

Exact text from the filing

On December 18, 2023, Catheter Precision, Inc. (formerly known as Ra Medical Systems, Inc.) (the “Company”) issued a press release announcing its financial results for the three and six months ended June 30, 2023.

View on SEC.gov

44 earnings releases filed in the last 30 days. Browse all earnings releases →

Catheter Precision, Inc. filing history →

Source: SEC EDGAR

accession 0001654954-23-015713

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.